Literature DB >> 20647400

Global patterns of cancer incidence and mortality rates and trends.

Ahmedin Jemal1, Melissa M Center, Carol DeSantis, Elizabeth M Ward.   

Abstract

While incidence and mortality rates for most cancers (including lung, colorectum, female breast, and prostate) are decreasing in the United States and many other western countries, they are increasing in several less developed and economically transitioning countries because of adoption of unhealthy western lifestyles such as smoking and physical inactivity and consumption of calorie-dense food. Indeed, the rates for lung and colon cancers in a few of these countries have already surpassed those in the United States and other western countries. Most developing countries also continue to be disproportionately affected by cancers related to infectious agents, such as cervix, liver, and stomach cancers. The proportion of new cancer cases diagnosed in less developed countries is projected to increase from about 56% of the world total in 2008 to more than 60% in 2030 because of the increasing trends in cancer rates and expected increases in life expectancy and growth of the population. In this review, we describe these changing global incidence and mortality patterns for select common cancers and the opportunities for cancer prevention in developing countries. (c)2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20647400     DOI: 10.1158/1055-9965.EPI-10-0437

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  975 in total

1.  Enhancing a cancer prevention and control curriculum through interactive group discussions.

Authors:  L P Forsythe; S M Gadalla; J G Hamilton; B M Heckman-Stoddard; E E Kent; G Y Lai; S W Lin; P Luhn; J M Faupel-Badger
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

2.  Quantifying the expression of tumor marker genes in lung squamous cell cancer with RNA sequencing.

Authors:  Lin Wang; Cheng Zhan; Yongxing Zhang; Jun Ma; Junjie Xi; Wei Jiang; Yu Shi; Qun Wang
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

3.  Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families.

Authors:  S M Schneegans; A Rosenberger; U Engel; M Sander; G Emons; M Shoukier
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

4.  Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro.

Authors:  Jingyao Zhang; Qifei Wu; Zhe Wang; Yong Zhang; Guangjian Zhang; Junke Fu; Chang Liu
Journal:  Tumour Biol       Date:  2014-11-15

5.  Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.

Authors:  Anita Jerome-Morais; Margaret E Wright; Rui Liu; Wancai Yang; Matthew I Jackson; Gerald F Combs; Alan M Diamond
Journal:  Prostate       Date:  2011-11-09       Impact factor: 4.104

6.  Worsening trends and increasing disparities in health-related quality of life: evidence from two French population-based cross-sectional surveys, 1995-2003.

Authors:  Etienne Audureau; Stéphane Rican; Joël Coste
Journal:  Qual Life Res       Date:  2013-02       Impact factor: 4.147

7.  Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma.

Authors:  E Christina Persson; Barry I Graubard; Alison A Evans; W Thomas London; Jean-Philippe Weber; Alain LeBlanc; Gang Chen; Wenyao Lin; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2012-03-15       Impact factor: 7.396

8.  Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trial.

Authors:  Suzanne G Orchard; Jessica E Lockery; Peter Gibbs; Galina Polekhina; Rory Wolfe; John Zalcberg; Andrew Haydon; John J McNeil; Mark R Nelson; Christopher M Reid; Brenda Kirpach; Anne M Murray; Robyn L Woods
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

9.  Improving the pathologic evaluation of lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.

Authors:  Binglan Zhang; Xuelei Ma; Zhimian Li; Xiang Gao; Fengtian Wang; Lei Liu; Guobo Shen; Yaxiong Sang; Minmin Li; Yuli Li; Jingyi Zhao; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.